(Q46990276)

English

Biotransformation and mass balance of tipranavir, a nonpeptidic protease inhibitor, when co-administered with ritonavir in Sprague-Dawley rats

scientific article published in September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Biotransformation and mass balance of tipranavir, a nonpeptidic protease inhibitor, when co-administered with ritonavir in Sprague-Dawley rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

1 reference

based on heuristic

inferred from title

author name string

Sreeraj Macha

1

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Linzhi Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Stephen H Norris

3

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Elsy Philip

4

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Yanping Mao

5

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Helga Silverstein

6

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Craig Struble

7

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Wendy Beers

8

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

publication date

1 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

59

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

9

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

1223-1233

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

A review of low-dose ritonavir in protease inhibitor combination therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Mechanism-based inactivation of CYP3A by HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Pharmacokinetic characterization of different dose combinations of coadministered tipranavir and ritonavir in healthy volunteers

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class∇

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0006

21 January 2018

Identifiers

10.1211/JPP.59.9.0006

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17883893

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46990276&oldid=2141003192"